Pfizer’s Panzyga Receives FDA Approval for Rare Neurological Disease
On February 12th, Pfizer announced it had received FDA approval for Panzyga to treat chronic inflammatory demyelinating polyneuropathy (CIDP), a rare neurological disease. CIDP is a rare neurological disease that …
Read More